Part 2, Reference for Chapter 16: Principles of Measurement and Assessment in Dermatology
Skip chapter table of contents and go to main content
- 1 Subjective and objective measurement methods in clinical dermatology from an historical perspective: the long way from Joseph Plenck to validation. Int J Dermatol 2006;45:1242–4. Cross Ref link Pubmed link , , , et al.
- 2 The COSMIN checklist for assessing the methodological quality of studies on measurement properties of health status measurement instruments: an international Delphi study. Qual Life Res 2010;19:539–49. Cross Ref link Pubmed link , , , et al.
- 3 Reliability testing of the dermatology index of disease severity (DIDS). An index for staging the severity of cutaneous inflammatory disease. Arch Dermatol 1997;133:1443–8. Cross Ref link Pubmed link , , , et al.
- 4 Using the Dermatology Index of Disease Severity (DIDS) to assess the responsiveness of dermatitis. Clin Exp Dermatol 2006;31:19–22. Cross Ref link Pubmed link , .
- 5 Severe psoriasis – oral therapy with a new retinoid. Dermatologica 1978;157:238–44. Cross Ref link Pubmed link , .
- 6 Measurement of involved surface area in patients with psoriasis. Br J Dermatol 1991;124:565–70. Cross Ref link Pubmed link , .
- 7 The self‐administered psoriasis area and severity index is valid and reliable. J Invest Dermatol 1996;106:183–6. Cross Ref link Pubmed link , Jr, , et al.
- 8 Performance of the self‐administered psoriasis area and severity index in evaluating clinical and sociodemographic subgroups of patients with psoriasis. Arch Dermatol 2003;139:353–8. Cross Ref link Pubmed link , , , et al.
- 9 Rethinking the Psoriasis Area and Severity Index: the impact of area should be increased. Br J Dermatol 2004;151:381–7. Cross Ref link Pubmed link , .
- 10 The National Psoriasis Foundation Psoriasis Score (NPF‐PS) system versus the Psoriasis Area Severity Index (PASI) and Physician's Global Assessment (PGA): a comparison. J Drugs Dermatol 2003;2:260–6. Pubmed link , , , et al.
- 11 Product of the Physician Global Assessment and body surface area: a simple static measure of psoriasis severity in a longitudinal cohort. J Am Acad Dermatol 2013;69:931–7. Cross Ref link Pubmed link , , , et al.
- 12 Evaluating psoriasis with Psoriasis Area and Severity Index, Psoriasis Global Assessment, and Lattice System Physician's Global Assessment. J Am Acad Dermatol 2004;51:563–9. Cross Ref link Pubmed link , .
- 13 A study examining inter‐ and intrarater reliability of three scales for measuring severity of psoriasis: Psoriasis Area and Severity Index, Physician's Global Assessment and Lattice System Physician's Global Assessment. Br J Dermatol 2006;155:707–13. Cross Ref link Pubmed link , , , et al.
- 14 Copenhagen Psoriasis Working Group. A study examining inter‐rater and intrarater reliability of a novel instrument for assessment of psoriasis: the Copenhagen Psoriasis Severity Index. Br J Dermatol 2008;159:407–12. Cross Ref link Pubmed link , , ;
- 15 The Simplified Psoriasis Index (SPI): a practical tool for assessing psoriasis. J Invest Dermatol 2013;133:1956–62. Cross Ref link Pubmed link , , .
- 16 Responsiveness to change and interpretability of the simplified psoriasis index. J Invest Dermatol 2014;134:351–8. Cross Ref link Pubmed link , , .
- 17 Nail Psoriasis Severity Index: a useful tool for evaluation of nail psoriasis. J Am Acad Dermatol 2003;49:206–12. Cross Ref link Pubmed link , .
- 18 The comparison of Nail Psoriasis Severity Index with a less time‐consuming qualitative system. J Eur Acad Dermatol Venereol 2008;22:219–22. Pubmed link , , .
- 19 Possible reconsideration of the Nail Psoriasis Severity Index (NAPSI) score. J Am Acad Dermatol 2013;69:1053–4. Cross Ref link Pubmed link , , , , .
- 20 Nail Assessment in Psoriasis and Psoriatic Arthritis (NAPPA): development and validation of a tool for assessment of nail psoriasis outcomes. Br J Dermatol 2014;170:591–8. Cross Ref link Pubmed link , , , et al.
- 21 Harmonizing Outcome Measurements in Eczema (HOME) Delphi panel. Core outcome domains for controlled trials and clinical recordkeeping in eczema: international multiperspective Delphi consensus process. J Invest Dermatol 2011;131:623–30. Cross Ref link Pubmed link , , , .
- 22 European Task Force. Severity scoring of atopic dermatitis: the SCORAD index. Consensus report of the European Task force on atopic dermatitis. Dermatology 1993;186:23–31. Cross Ref link Pubmed link
- 23 European Dermato‐Epidemiology Network. What are the best outcome measurements for atopic eczema? A systematic review. J Allergy Clin Immunol 2007;120:1389–98. Cross Ref link Pubmed link , , ;
- 24 Harmonising Outcome Measures for Atopic Dermatitis (HOME) Initiative. Assessment of clinical signs of atopic dermatitis: a systematic review and recommendation. J Allergy Clin Immunol 2013;132:1337–47. Cross Ref link Pubmed link , , , et al.
- 25 Guidelines of care for the management of atopic dermatitis: section 1. Diagnosis and assessment of atopic dermatitis. J Am Acad Dermatol 2014;70:338–51. Cross Ref link Pubmed link , , , et al.
- 26 EASI, (objective) SCORAD and POEM for atopic eczema: responsiveness and minimal clinically important difference. Allergy 2012;67:99–106. Cross Ref link Pubmed link , , , , , .
- 27 Clinical validation and guidelines for the SCORAD index: consensus report of the European Task Force on atopic dermatitis. Dermatology 1997;195:10–19. Cross Ref link Pubmed link , , , et al.
- 28 Scoring atopic dermatitis in infants and young children: distinctive features of the SCORAD index. Allergy 2005;60:113–16. Cross Ref link Pubmed link , , , et al.
- 29 Practical issues on interpretation of scoring atopic dermatitis: SCORAD Index, objective SCORAD, patient‐oriented SCORAD and Three‐Item Severity score. Curr Probl Dermatol 2011;41:149–55. Cross Ref link Pubmed link .
- 30 Clinical validation and guidelines for the SCORAD index: consensus report of the European Task Force on atopic dermatitis. Dermatology 1997;195:10–19. Cross Ref link Pubmed link , , , et al.
- 31 SCORAD 75: a new metric for assessing treatment outcomes in atopic dermatitis. J Eur Acad Dermatol Venereol 2012;26:1510–15. Cross Ref link Pubmed link , , , , .
- 32 The eczema area and severity index (EASI): assessment of reliability in atopic dermatitis. Exp Dermatol 2001;10:11–18. Cross Ref link Pubmed link , , , et al.
- 33 Validation of the Eczema Area and Severity Index for atopic dermatitis in a cohort of 1550 patients from the pimecrolimus cream 1% randomized controlled clinical trials programme. Br J Dermatol 2004;150:96–102. Cross Ref link Pubmed link , , , et al.
- 34 Use of the Self‐Administered Eczema Area and Severity index by parent caregivers: results of a validation study. Br J Dermatol 2002;147:1192–8. Cross Ref link Pubmed link , , , et al.
- 35 The patient‐orientated eczema measure: development and initial validation of a new tool for measuring atopic eczema from the patient's perspective. Arch Dermatol 2004;140:1513–19. Cross Ref link Pubmed link , , .
- 36 Grading of the severity of atopic dermatitis. Acta Derm Venereol Suppl (Stockh) 1989;144:13–14. Pubmed link , .
- 37 The Nottingham Eczema Severity Score: preliminary refinement of the Rajka and Langeland grading. Br J Dermatol 2000;142:288–97. Cross Ref link Pubmed link , , .
- 38 Six area, six sign atopic dermatitis (SASSAD) severity score: a simple system for monitoring disease activity in atopic dermatitis. Br J Dermatol 1996;135(Suppl. 48):25–30. Cross Ref link Pubmed link .
- 39 Reliability testing of the six area, six sign atopic dermatitis severity score. Br J Dermatol 2002;146:1057–60. Cross Ref link Pubmed link , , .
- 40 Scoring the severity of atopic dermatitis: three item severity score as a rough system for daily practice and as a pre‐screening tool for studies. Acta Derm Venereol 1999;79:356–9. Cross Ref link Pubmed link , , , et al.
- 41 Measuring atopic eczema severity visually: which variables are the most important? Arch Dermatol 2005;141:1146–51. Cross Ref link Pubmed link , , , .
- 42 The Objective Severity Assessment Atopic Dermatitis score. Arch Dermatol 2003;139:1417–22. Cross Ref link Pubmed link , , , et al.
- 43 The Objective Severity Assessment of Atopic Dermatitis (OSAAD) score: validity, reliability and sensitivity in adult patients with atopic dermatitis. Br J Dermatol 2005;153:767–73. Cross Ref link Pubmed link , , , et al.
- 44 Serum measurement of interleukin‐31 (IL‐31) in paediatric atopic dermatitis: elevated levels correlate with severity scoring. J Eur Acad Dermatol Venereol 2011;25:334–9. Cross Ref link Pubmed link , , .
- 45 Outcome measures in acne vulgaris: systematic review. Br J Dermatol 2009;160:132–6. Cross Ref link Pubmed link , , , , , .
- 46 The assessment of acne: an evaluation of grading and lesion counting in the measurement of acne. Clin Dermatol 2004;22:394–7. Cross Ref link Pubmed link , .
- 47 The Leeds revised acne grading system. J Dermatol Treatment 1998;9:215–20. Cross Ref link , , .
- 48 The assessment of acne vulgaris – the Leeds technique. Br J Dermatol 1984;111:83–92. Cross Ref link Pubmed link , .
- 49 An acne grading method using photographic standards. Arch Dermatol 1979;115:571–5. Cross Ref link Pubmed link , , .
- 50 New photographic techniques for clinical evaluation of acne. J Eur Acad Dermatol Venereol 2001;15 (Suppl. 3):13–18. Pubmed link , .
- 51 ECLA grading: a system of acne classification for every day dermatological practice. Ann Dermatol Venereol 1999;126:136–41. Pubmed link , , , et al.
- 52 Clinical and psychological correlation in acne: use of the ECLA and CADI scales. Ann Dermatol Venereol 2007;134:451–5. Cross Ref link Pubmed link , , , et al.
- 53 Severity of acne and its impact on quality of life. Skinmed 2013;11:148–53. Pubmed link , , , , , .
- 54 Postacne scarring – a quantitative global scarring system. J Cosmet Dermatol 2006;5:48–52. Cross Ref link Pubmed link , .
- 55 ECCA grading scale: an original validated acne scar grading scale for clinical practice in dermatology. Dermatology 2007;214:46–51. Cross Ref link Pubmed link , , , et al.
- 56 Comparison of a 585‐nm pulsed dye laser and a 1064‐nm Nd:YAG laser for the treatment of acne scars: A randomized split‐face clinical study. J Am Acad Dermatol 2009;60:801–7. Cross Ref link Pubmed link , , , , .
- 57 Pathophysiology of nocturnal scratching in childhood atopic dermatitis: the role of the brain‐derived neurotrophic factor and substance P. Br J Dermatol 2007;157:922–5. Cross Ref link Pubmed link , , , et al.
- 58 Assessment of pruritus – current standards and implications for clinical practice: consensus paper of the Action Group Pruritus Parameter of the International Working Group on Pruritus Research (AGP). Hautarzt 2012;63:521–2, 524–31. Cross Ref link Pubmed link , , , et al.
- 59 Itch Severity Scale: a self‐report instrument for the measurement of pruritus severity. Br J Dermatol 2007;156:667–73. Cross Ref link Pubmed link , , , .
- 60 International Forum on the Study of Itch. Questionnaires to assess chronic itch: a consensus paper of the special interest group of the International Forum on the Study of Itch. Acta Derm Venereol 2012;92:493–6. Cross Ref link Pubmed link , , , , , ;
- 61 Validation of the Psoriasis Symptom Inventory (PSI), a patient‐reported outcome measure to assess psoriasis symptom severity. J Dermatol Treat 2013;24:356–60. Cross Ref link , , , et al.
- 62 Equivalence and measurement properties of an electronic version of the Psoriasis Symptom Inventory. Qual Life Res 2014;23:897–906. Cross Ref link Pubmed link , , , , , .
- 63 The patient benefit index: a novel approach in patient‐defined outcomes measurement for skin diseases. Arch Dermatol Res 2009;301:561–71. Cross Ref link Pubmed link , , , et al.
- 64 Validation of the patient benefit index for the assessment of patient‐relevant benefit in the treatment of psoriasis. Arch Dermatol Res 2012;304:433–41. Cross Ref link Pubmed link , , , .
- 65 Handbook of Non‐invasive Methods and the Skin, 2nd edn. Boca Raton, Florida: Taylor and Francis, 2006. Cross Ref link , , , eds.
- 66 Skin thickness measurement by pulsed ultrasound; its reproducibility, validation and variability. Br J Dermatol 1982;106:657–67. Pubmed link , , , .
- 67 Ultrasound evaluation of clobetasol propionate 0.05% foam application in psoriatic and healthy skin: a pilot study. Dermatol Ther 2009;22 Suppl. 1:S19–21. Cross Ref link Pubmed link , , , .
- 68 A comparison of subjective and objective measures of reduction of psoriasis with the use of ultrasound, reflectance colorimetry, computerized video image analysis, and nitric oxide production. J Am Acad Dermatol 1997;37:51–7. Cross Ref link Pubmed link , , , et al.
- 69 Assessment of skin barrier function in podoconiosis: measurement of stratum corneum hydration and transepidermal water loss. Br J Dermatol 2013;168:550–4. Cross Ref link Pubmed link , , , , , .
- 70 Capacitance imaging of the skin surface. Skin Res Technol 2006;12:99–104. Cross Ref link Pubmed link , , .
- 71 Comparison of skin hydration evaluation sites and correlations among skin hydration, transepidermal water loss, SCORAD index, Nottingham Eczema Severity Score, and quality of life in patients with atopic dermatitis. Am J Clin Dermatol 2008;9:45–50. Cross Ref link Pubmed link , , , et al.
- 72 Morphology and epidermal thickness of normal skin imaged by optical coherence tomography. Dermatology 2008;217:14–20. Cross Ref link Pubmed link , , , .
- 73 Guidelines for measurement of skin colour and erythema. Contact Dermatitis 1996;35:1–10. Cross Ref link Pubmed link , , , et al.
- 74 A device for the color measurement and detection of spots on the skin. Skin Res Technol 2008;14:65–70. Pubmed link , , , et al.
- 75 Non‐invasive measurements of skin pigmentation in situ. Pigment Cell Res 2004;17:616–26. Cross Ref link , , , .
- 76 Skin melanin, hemoglobin, and light scattering properties can be quantitatively assessed in vivo using diffuse reflectance spectroscopy. J Invest Dermatol 2001;117:1452–7. Cross Ref link Pubmed link , , .
- 77 Measurement of skin elasticity on the foot. Skin Res Technol 2007;13:252–8. Cross Ref link Pubmed link , .
- 78 Comparison of two in vivo measurements for skin surface topography. Skin Res Technol 2013;19:84–90. Cross Ref link Pubmed link , , , , , .
- 79 Global assessment of psoriasis severity and change from photographs: a valid and consistent method. J Invest Dermatol 2008;128:198–203. , , .
- 80 Body surface area measurement and soft clustering for PASI area assessment. Conf Proc IEEE Eng Med Biol Soc 2012;2012:4398–401. Pubmed link , , , , .
- 81 Computer‐aided measurement of psoriatic lesion area in a multicenter clinical trial – comparison to physician's estimations. J Dermatol Sci 2006;44:21–7. Cross Ref link Pubmed link , , , et al.
- 82 A practical method for the estimation of vitiligo surface area: a comparison between the point counting and digital planimetry techniques. Eur J Dermatol 2007;17:30–2. Pubmed link , , , et al.
- 83 Dermatology patients: what do they really need? Clin Exp Dermatol 2000;25:444–50. Cross Ref link Pubmed link .
- 84 Quality of Life: a deconstruction for clinicians. J R Soc Med 2002;95:481–8. Cross Ref link Pubmed link , .
- 85 Health‐related quality of life: from health economics to bedside. Dermatology 2007;215:273–6. Cross Ref link Pubmed link .
- 86 Quality of life in cancer patients – an hypothesis. J Med Ethics 1984;10:124–7. Cross Ref link Pubmed link .
- 87 German psoriasis registry PsoBest: objectives, methodology and baseline data. J Dtsch Dermatol Ges 2014;12:48–57. Pubmed link , , , et al.
- 88 All Party Parliamentary Group on Skin. The psychological and social impact of skin diseases on people's lives. A report of the All Party Parliamentary Group on Skin, London, 2013.
- 89 Impact of skin diseases on quality of life. In: Barker J, Burgdorf W, eds. EDF White Book, 3rd edn. Berlin: European Dermatology Forum (EDF), 2010:15–16. , .
- 90 Validation of sickness impact profile and psoriasis disability index in psoriasis. Br J Dermatol 1990;123:751–6. Cross Ref link Pubmed link , , , .
- 91 Psoriasis causes as much disability as other major medical diseases. J Am Acad Dermatol 1999;41:401–7. Cross Ref link Pubmed link , , , et al.
- 92 Patient–physician consensus and quality of life in dermatology. Clin Exp Dermatol 1996;21:177–9. Cross Ref link Pubmed link , .
- 93 Patients' and doctors' assessment of skin disease handicap. Clin Exp Dermatol 2002;27:1–3. Cross Ref link , , .
- 94 Impairment of sexual life in patients with psoriasis. Dermatology 2007;214:144–50. Cross Ref link Pubmed link , , , et al.
- 95 Implementing best practice in psoriasis: a Nordic Expert Group Consensus. Acta Derm Venereol 2014;94:547–52. Cross Ref link Pubmed link , , , , .
- 96 Current severe psoriasis and the Rule of Tens. Br J Dermatol 2005;152:861–7. Cross Ref link Pubmed link .
- 97 British Association of Dermatologists' guidelines for biologic interventions for psoriasis 2009. Br J Dermatol 2009;161:987–1019. Cross Ref link Pubmed link , , , et al.
- 98 National Institute for Health and Clinical Guidance. CG153. Psoriasis: The Assessment and Management of Psoriasis, October 2012 www.nice.org.uk/guidance/cg153 (last accessed October 2015).
- 99 Treatment goals for moderate to severe psoriasis: an Australian consensus. Australas J Dermatol 2013;54:148–54. Cross Ref link Pubmed link , , , et al.
- 100 Recommendations for the use of etanercept in psoriasis: a European dermatology expert group consensus. J Eur Acad Dermatol Venereol 2006;20:988–98. Pubmed link , , , et al.
- 101 Highlights from the report of the Working Group on ‘Core measures of the burden of skin diseases’. J Invest Dermatol 2007;127:2701–6. Cross Ref link Pubmed link , , , et al.
- 102 EADV Taskforce on Quality of Life. Measurement of health‐related quality of life in dermatological research and practice: outcome of the EADV Taskforce on Quality of Life. J Eur Acad Dermatol Venereol 2013;27:1195–203. Pubmed link , , , et al.
- 103 Quality of life measurement in dermatology: a practical guide. Br J Dermatol 1997;136:305–14. Cross Ref link Pubmed link .
- 104 A brief guide to the selection of quality of life instrument. Health Qual Life Outcomes 2003;1:24. Cross Ref link Pubmed link .
- 105 Critical review of generic and dermatology‐specific health‐related quality of life instruments. J Invest Dermatol 2007;127:2726–39. Cross Ref link Pubmed link , , , .
- 106 Comparison of assessments of severity and quality of life in cutaneous disease. Clin Exp Dermatol 2002;27:306–8. Cross Ref link Pubmed link , , , .
- 107 The suitability of quality‐of‐life questionnaires for psoriasis research: a systematic literature review. Arch Dermatol 2002;138:1221–7. Cross Ref link Pubmed link , , , .
- 108 Understanding research about quality of life and other health outcomes. J Cut Med Surg 1999;3:312–16. .
- 109 Research methodology in quality of life assessment. In: , , eds. Psychodermatology. Cambridge: Cambridge University Press, 2005. .
- 110 Dermatology Quality of Life instruments: sorting out the quagmire. J Invest Dermatol 2007;127:2695–6. Cross Ref link Pubmed link .
- 111 Psychometric properties of the Dermatology life Quality Index (DLQI) in 900 Italian patients with psoriasis. Acta Derm Venereol 2005;85:409–13. Cross Ref link Pubmed link , , , et al.
- 112 Dimensionality of the Dermatology Life Quality Index (DLQI): a commentary. Acta Derm Venereol 2006;86:284–5. Cross Ref link Pubmed link , , .
- 113 Translating the science of quality of life into practice: what do Dermatology Life Quality Index scores mean? J Invest Dermatol 2005;125:659–64. Cross Ref link Pubmed link , , , et al.
- 114 Categorization of Skindex‐29 scores using mixture analysis. Dermatology 2009;218:151–4. Cross Ref link Pubmed link , , .
- 115 Clinical Meaning in Skin‐specific Quality of Life Instruments: A Comparison of the Dermatology Life Quality Index and Skindex Banding Systems. Dermatol Clin 2012;30:333–42. Cross Ref link Pubmed link , , .
- 116 Cross‐cultural inequivalence of dermatology‐specific health‐related quality of life instruments in psoriasis patients. J Invest Dermatol 2007;127:2315–22. Cross Ref link Pubmed link , , , et al.
- 117 The Sickness Impact Profile: development and final revision of a health status measure. Med Care 1981;19:787–805. Cross Ref link Pubmed link , , , et al.
- 118 The effect of treatment on quality of life in psoriasis patients. Acta Derm Venereol 2005;85:304–10. Pubmed link , , , et al.
- 119 Cyclosporin greatly improves the quality of life of adults with severe atopic dermatitis. Br J Dermatol 1993;129:422–30. Cross Ref link Pubmed link , , , et al.
- 120 The MOS 36‐Item Short‐Form Health Survey (SF‐36). 1. Conceptual framework and item selection. Med Care 1992;30:437–83. , .
- 121 Measuring quality of life of patients with different clinical types of psoriasis using the SF‐36. Br J Dermatol 2006;154:844–9. Cross Ref link Pubmed link , , , et al.
- 122 Comparison of Skindex‐29, Dermatology Life Quality Index, Psoriasis Disability Index and Medical Outcome Study Short Form 36 in patients with mild to severe psoriasis.Br J Dermatol 2012;166:884–7. Cross Ref link Pubmed link , , , .
- 123 The levels of depression, anxiety and quality of life in patients with chronic idiopathic urticaria. J Eur Acad Dermatol Venereol 2008;22:36–40. Pubmed link , , , et al.
- 124 How does psoriasis affect quality of life? Assessing an Ingram‐regimen outpatient programme and validating the WHOQOL‐100. Br J Dermatol 2006;154:680–91. Cross Ref link Pubmed link , , , et al.
- 125 Twelve years' experience with the Patient Generated Index (PGI) of quality of life: a graded structured review. Qual Life Res 2007;16:705–15. Cross Ref link Pubmed link , , , et al.
- 126 Practical and methodological issues in the development of the EuroQol: the York experience. Adv Med Sociol 1994;5:219–53. , , , .
- 127 EQ‐5D Value Sets: inventory, comparative review and user guide. Berlin: Springer, 2007. Cross Ref link , , , eds.
- 128 The role of the EQ‐5D in the economic evaluation of dermatological conditions and therapies. Dermatology 2012;225:45–53. Cross Ref link Pubmed link , , , .
- 129 Assessing psychological distress in patients with skin diseases: reliability, validity and factor structure of the GHQ‐12. J Eur Acad Dermatol Venereol 2001;15:410–17. Cross Ref link Pubmed link , , .
- 130 Depression in dermatological patients identified by the Mini International Neuropsychiatric Interview questionnaire. J Am Acad Dermatol 2006;54:94–9. Cross Ref link Pubmed link , , , et al.
- 131 Quality of life in patients with chronic urticaria is differentially impaired by psychiatric comorbidity. Br J Dermatol 2006;154:294–8. Cross Ref link Pubmed link , , , et al.
- 132 Dermatology Life quality Index (DLQI): a simple practical measure for routine clinical use. Clin Exp Dermatol 1994;19:210–16. Cross Ref link Pubmed link , .
- 133 Skindex, a Quality‐of‐life measure for patients with skin diseases: reliability, validity, and responsiveness. J Invest Dermatol 1996;107:707–13. Cross Ref link Pubmed link , , , et al.
- 134 Dermatology quality of Life scales – a measure of the impact of skin diseases. Br J Dermatol 1997;136:202–6. Cross Ref link Pubmed link , , , .
- 135 Development and validation of a quality of life instrument for cutaneous diseases. J Am Acad Dermatol 1997;37:41–50. Cross Ref link Pubmed link , .
- 136 German instrument for the assesment of quality of life in skin diseases (DIELH). Internal consistency, reliability, convergent and discriminant validity and responsiveness. Hautarzt 2001;52(7):624–8. Cross Ref link Pubmed link , , .
- 137 Comparative study of the impact of chronic urticaria, psoriasis and atopic dermatitis on the quality of life. Br J Dermatol 2005;152:289–95. Cross Ref link Pubmed link , , , et al.
- 138 Quality of life instrument for Turkish people with skin diseases. Int J Dermatol 2005;44:933–8. Cross Ref link Pubmed link , , , et al.
- 139 Development, validation and clinical use of the FLQA‐I, a disease‐specific quality of life questionnaire for patients with lymphedema. Vasa 2005;34:31–5. Cross Ref link Pubmed link , , , et al.
- 140 Pictorial Representation of Illness and Self Measure (PRISM): A novel visual instrument to measure quality of life in dermatological inpatients. Arch Dermatol 2009;145:774–80. Cross Ref link Pubmed link , , , , , .
- 141 van de Kerkhof PCM, et al. The impact of chronic skin disease on daily life (ISDL): a generic and dermatology‐specific health instrument. Br J Dermatol 2008;158:101–8. Pubmed link , ,
- 142 Dermatology Life Quality Index: influence of an illustrated version. Br J Dermatol 2003;148:279–84. Cross Ref link Pubmed link , , , .
- 143 The Dermatology Life Quality Index 1994–2007: a comprehensive review of validation data and clinical results. Br J Dermatol 2008;159:997–1035. Pubmed link , , , et al.
- 144 Dermatology Life Quality Index (DLQI): Department of Dermatology, Cardiff University www.cardiff.ac.uk/dermatology/quality‐of‐life/ (last accessed October 2015).
- 145 Impaired quality of life of adults with skin disease in primary care. Br J Dermatol 2000;143:979–82. Cross Ref link Pubmed link , , , .
- 146 Measuring health‐related quality of life in patients with mild to moderate eczema and psoriasis: clinical validity, reliability and sensibility to change of the DLQI. Br J Dermatol 1999;141:698–702. Cross Ref link Pubmed link , , .
- 147 Quality of life in skin diseases: methodological and practical comparison of different quality of life questionnaires in psoriasis and atopic dermatitis. Hautarzt 1999;50:715–22. Cross Ref link Pubmed link , , , et al.
- 148 Dermatology life quality index: data from Danish inpatients and outpatients. Acta Derm Venereol 2000;80:272–6. Cross Ref link Pubmed link , , , et al.
- 149 Use of the Dermatology Life Quality Index (DLQI) in a Midwestern US urban clinic. J Am Acad Dermatol 2001;45:44–8. Cross Ref link Pubmed link , , , et al.
- 150 The Norwegian version of the Dermatology Life Quality Index: a study of validity and reliability in psoriatics. Acta Derm Venereol 2002;82:327–51. , , .
- 151 Sensitivity of the Dermatology Life Quality Index to clinical change in patients with psoriasis. Br J Dermatol 2003;149:318–22. Cross Ref link Pubmed link , , , et al.
- 152 Dermatology Life Quality Index (DLQI): Polish version. Dermatol Kliczna 2004;6:63–70. , , , et al.
- 153 DLQI scores in vitiligo: reliability and validity of the Persian version. BMC Dermatol 2004;4:8 Cross Ref link Pubmed link , , , et al.
- 154 The impact of lupus erythematosus on the quality of life: the Brazilian‐Portugese version of DLQI. Qual Life Res 2006;15:565–70. Cross Ref link Pubmed link , , , et al.
- 155 Japanese version of the Dermatology Life Quality Index: validity and reliability in patients with acne. Health Qual Life Outcomes 2006;4:46. Cross Ref link Pubmed link , , , et al.
- 156 Validation study of Sinhala version of the dermatology life quality index (DLQI). Ceylon Med J 2011;56:18–22. Pubmed link , , .
- 157 Minimum clinically important difference in Dermatology Life Quality Index in moderate to severe plaque psoriasis patients treated with Adalimumab. J Am Acad Dermatol 2005;52 (Suppl.):AB221. , , .
- 158 Minimal important difference (MID) of the Dermatology Life Quality Index (DLQI): results from patients with chronic idiopathic urticaria. Health Qual Life Outcomes 2005;3:36. Cross Ref link Pubmed link , , , .
- 159 Clinical meaning of change in Dermatology Life Quality Index scores. Br J Dermatol 2002;147 (Suppl. 62):50. , , .
- 160 Determining the minimal clinically important difference and responsiveness of the Dermatology Life Quality Index (DLQI): further data. Dermatology 2015;230:27–33. Cross Ref link Pubmed link , , , , .
- 161 Dermatology life quality index: time to move forward. J Invest Dermatol 2012;132:11–13. Cross Ref link Pubmed link .
- 162 Dermatology life quality index (DLQI): a paradigm shift to patient‐centered outcomes. J Invest Dermatol 2012;132:2464–5. Cross Ref link Pubmed link , , , .
- 163 Improved discriminative and evaluative capability of a refined version of Skindex, a quality‐of‐life instrument for patients with skin diseases. Arch Dermatol 1997;133:1433–40. Cross Ref link Pubmed link , , , .
- 164 Measurement properties of Skindex‐16: a brief quality‐of‐life measure for patients with skin diseases. J Cutan Med Surg 2001;5:105–10. Cross Ref link Pubmed link , , , .
- 165 Testing and reducing Skindex‐29 using Rasch analysis: Skindex‐17. J Invest Dermatol 2006;126:1244–50. Cross Ref link Pubmed link , , , .
- 166 The Spanish version of Skindex‐29. Int J Dermatol 2000;39:907–12. Cross Ref link Pubmed link , , , et al.
- 167 Further evidence of the validity and reliability of the Skindex‐29: an Italian study on 2,242 dermatological outpatients. Dermatology 2002;204:43–9. Cross Ref link Pubmed link , , , et al.
- 168 Turkish version of Skindex‐29. Int J Dermatol 2007;46:350–5. Cross Ref link Pubmed link , , , et al.
- 169 Arabic version of Skindex‐16: translation and cultural adaptation, with assessment of reliability and validity. Int J Dermatol 2007;46:247–52. Cross Ref link Pubmed link , .
- 170 The Japanese version of Skindex‐16: a brief quality‐of‐life measure for patients with skin disease. J Dermatol 2002;29:693–8. Cross Ref link Pubmed link , , , et al.
- 171 German adaptation of the Skindex‐29 questionnaire on quality of life in dermatology: validation and clinical results. Dermatology 2004;209:14–20. Cross Ref link Pubmed link , , , et al.
- 172 Adaptation of a Runyankore version of Skindex‐16 for oral administration in Mbarara, Uganda. Int J Dermatol 2011;50:1249–54. Cross Ref link Pubmed link , , .
- 173 Validation of the Skindex‐16 questionnaire in patients with skin diseases in Morocco. J Dermatol Treat 2014;25:106–9. Cross Ref link , , , et al.
- 174 What are the best outcome measures for assessing quality of life in plaque type psoriasis? A systematic review of the literature. J Eur Acad Dermatol Venereol 2010;24 Suppl. 2:17–22. Cross Ref link Pubmed link , , , et al.
- 175 Measuring the effects of psoriasis on quality of life. Exp Rev Dermatol 2006;1(5):723–6. Cross Ref link , .
- 176 Quality of life measures in psoriasis: a systematic literature review. J Invest Dermatol Symp Proc 2004;9:140–7. Cross Ref link , , , .
- 177 Psoriasis – an index of disability. Clin Exp Dermatol 1987;12:8–11. Cross Ref link Pubmed link , .
- 178 The effect of severe psoriasis on the quality of life of 369 patients. Br J Dermatol 1995;132:236–44. Cross Ref link Pubmed link , .
- 179 European patient perspectives on the impact of psoriasis: the EUROPSO patient membership survey. Br J Dermatol 2006;155:729–36. Cross Ref link Pubmed link , , , et al.
- 180 Two decades experience of the Psoriasis Disability Index. Dermatology 2005;210:261–8. Cross Ref link Pubmed link , .
- 181 What characterizes the severity of psoriasis? Dermatology 2008;216:137–51. Cross Ref link Pubmed link , , , et al.
- 182 The psychometric properties of the psoriasis disability index in United States patients. J Invest Dermatol 2005;125:665–72. Cross Ref link Pubmed link , , , et al.
- 183 Feelings of stigmatisation in patients with psoriasis. J Am Acad Dermatol 1989;20:53–63. Cross Ref link Pubmed link , .
- 184 Dimensions of stigmatisation in patients with psoriasis in a ‘questionnaire on experience with skin complaints’. Dermatology 1996;193:304–10. Cross Ref link Pubmed link , , , .
- 185 Experiences of stigmatisation play a role in mediating the impact of disease severity on quality of life in psoriasis patients. Br J Dermatol 2002;147:736–42. Cross Ref link Pubmed link , , , et al.
- 186 Self‐reported stress reactivity and psoriasis‐related stress of Nordic psoriasis sufferers. J Eur Acad Dermatol Venereol 2004;18:27–36. Cross Ref link Pubmed link , , , et al.
- 187 The Psoriasis Life Stress Inventory: a preliminary index of psoriasis‐related stress. Acta Dermatol Venereol (Stockh) 1995;75:240–3. , .
- 188 The impact of psoriasis on the quality of life of patients from the 16‐center PUVA follow‐up cohort. J Am Acad Dermatol 1997;36:388–94. Cross Ref link Pubmed link , .
- 189 Refinement and reduction of the Impact of Psoriasis Questionnaire: classical test theory vs. Rasch analysis. Br J Dermatol 2006;154:692–700. Cross Ref link Pubmed link , , .
- 190 Impact of psoriasis on health‐related quality of life decreases over time: an 11‐year prospective study. J Invest Dermatol 2006;126:1480–9. Cross Ref link Pubmed link , , , et al.
- 191 Development of the PSORIQoL, a psoriasis specific measure of quality of life designed for use in clinical practice and trials. Br J Dermatol 2003;149:323–31. Cross Ref link Pubmed link , , , et al.
- 192 Development of the US PSORIQoL: a psoriasis‐specific measure of quality of life. Int J Dermatol 2005;44:462–9. Cross Ref link Pubmed link , , .
- 193 Quality‐of‐life issues in psoriasis and psoriatic arthritis outcome measures and therapies from a dermatological perspective. J Am Acad Dermatol 2006;54:685–704. Cross Ref link Pubmed link , .
- 194 Decision points for the initiation of systemic treatment for psoriasis. J Am Acad Dermatol 2005;53:101–7. Cross Ref link Pubmed link , , , .
- 195 Measuring quality of life in psoriasis: the CALIPSO questionnaire. Eur J Dermatol 2011;21:67–78. Pubmed link , , , .
- 196 The effect of atopic dermatitis on total burden of illness and quality of life on adults and children in a large managed care organisation. J Managed Care Pharmacy 2002;8:333–42. , , , et al.
- 197 The burden of atopic eczema. In: Ring J, Przybila B, Ruzicka T, eds. Handbook of Atopic Eczema, 2nd edn. Berlin: Springer, 2006. .
- 198 Development and validation of the psychosomatic scale for atopic dermatitis in adults. J Dermatol 2006;33:439–50. Cross Ref link Pubmed link , , , et al.
- 199 The impact of psychological and clinical factors on quality of life in individuals with atopic dermatitis. J Psychosom Res 2004;57:195–200. Cross Ref link Pubmed link , , , .
- 200 Development of the Childhood Atopic Dermatitis Impact Scale: initial validation of a quality‐of‐life measure for young children with atopic dermatitis and their families. J Invest Dermatol 2005;125:1106–11. Cross Ref link Pubmed link , , , et al.
- 201 Childhood Atopic Dermatitis Impact Scale: reliability, discriminative and concurrent validity and responsiveness. Arch Dermatol 2007;143:768–72. Cross Ref link Pubmed link , , , et al.
- 202 Italian validation of the Childhood Atopic Dermatitis Impact Scale: a contribution to its clinical application. J Invest Dermatol 2012;132:2534–43. Cross Ref link Pubmed link , , , et al.
- 203 International development of the parents' index of quality of life in atopic dermatitis (PIQoL‐AD). Qual Life Res 2005;14:231–41. Cross Ref link Pubmed link , , , et al.
- 204 The quality of life of parents of children with atopic dermatitis; interpretation of PIQoL scores. Qual Life Res 2005;14:2235–45. Cross Ref link Pubmed link , , .
- 205 The family impact of childhood atopic dermatitis: the Dermatitis Family Impact questionnaire. Br J Dermatol 1998;138:107–13. Cross Ref link Pubmed link , , , et al.
- 206 The Infant's Dermatitis Quality of Life Index. Br J Dermatol 2001;144:104–10. Cross Ref link Pubmed link , , .
- 207 Infants' Dermatitis Quality of Life Index: a decade of experience of validation and clinical application. Br J Dermatol 2013;169:760–8. Cross Ref link Pubmed link , , , , .
- 208 Practical use of a disability index in the routine management of acne. Clin Exp Dermatol 1992;17:1–3. Cross Ref link Pubmed link , .
- 209 How much disability is caused by acne? Clin Exp Dermatol 1989;14:194–8. Cross Ref link Pubmed link , .
- 210 Questionnaire techniques in assessing acne handicap: reliability and validity study. Qual Life Res 1996;5:131–8. Cross Ref link Pubmed link , , .
- 211 The Cardiff Acne Disability Index: cultural and linguistic validation in French. Dermatology 2004;208:104–8. Cross Ref link Pubmed link , , , et al.
- 212 The Persian version of the Cardiff Acne Disability Index. Saudi Med J 2006;27:447–9. , , , .
- 213 The Cardiff Acne Disability Index (CADI): linguistic and cultural validation in Serbian. Qual Life Res 2013;22:161–6. Cross Ref link Pubmed link , , , , , .
- 214 Quality of life and acne in Scottish adolescent schoolchildren: use of the Children's Dermatology Life Quality Index (CDLQI) and the Cardiff Acne Disability Index (CADI). J Eur Acad Dermatol Venereol 2006;20:45–50. Cross Ref link Pubmed link , .
- 215 Psychological assessment of skin disease. Interfaces Dermatol 1994;1:37–9. .
- 216 Which factors influence quality of life in acne patients? J Eur Acad Dermatol Venereol 2014;28:46–50. Cross Ref link Pubmed link , , , et al.
- 217 The development of an acne quality of life scale: reliability, validity, and relation to subjective acne severity in mild to moderate acne vulgaris. Acta Derm Venereol (Stockh) 1998;78:451–6. Cross Ref link , , .
- 218 Health‐related quality of life among patients with facial acne – assessment of a new acne‐specific questionnaire. Clin Exp Dermatol 2001;26:380–5. Cross Ref link Pubmed link , , , et al.
- 219 Condensation and validation of a 4‐item index of the Acne‐QoL. Qual Life Res 2006;15:1203–10. Cross Ref link Pubmed link , , .
- 220 Evaluation of the French version of the 4‐item index of the Acne‐QoL (AcneQ4fr). Qual Life Res 2013;22:547–9. Cross Ref link Pubmed link , , , , .
- 221 Development of a new patient‐reported outcome measure for facial acne: the Acne Symptom and Impact Scale (ASIS). J Drugs Dermatol 2014;13:333–40. Pubmed link , , , , , .
- 222 A new approach to the measurement of quality of life. The patient generated index. Med Care 1994:32:1109–26. Cross Ref link Pubmed link , , , et al.
- 223 Measurement of quality of life in atopic dermatitis: correlation and validation of two different methods. Br J Dermatol 1997;136: 502–7. Cross Ref link Pubmed link , , , JAA.
- 224 Quality of life, health state utilities and willingness to pay in patients with psoriasis and atopic eczema. Br J Dermatol 1999;141:1067–75. Cross Ref link Pubmed link , , , et al.
- 225 Willingness to pay and time trade‐off: sensitive to changes of quality of life in psoriasis patients? Br J Dermatol 2003;148:1153–60. Cross Ref link Pubmed link , , , et al.
- 226 Measures of the effect of adult severe atopic eczema on quality of life. J Eur Acad Dermatol Venereol 1996;7:149–54. Cross Ref link .
- 227 Cham PMH, , , et al. Reliability of self‐reported willingness‐to‐pay and annual income in patients treated for toenail onychomycosis. Br J Dermatol 2007;156:922–8. Cross Ref link Pubmed link
- 228 Measuring melasma patients' quality of life using willingness to pay and time trade‐off methods in Thai population. BMC Dermatol 2011 Dec 19;11:16. Cross Ref link Pubmed link , , , .
- 229 Assessment of health state utilities of controlled and uncontrolled psoriasis and atopic eczema: a population‐based study. Br J Dermatol 2008;158:351–9. Cross Ref link Pubmed link , , , .
- 230 A catalog of dermatologic utilities: a measure of the burden of skin diseases. J Invest Dermatol Symp Proc 2004;9:160–8. Cross Ref link , , , et al.
- 231 Social and economic aspects of acne and the cost‐effectiveness of isotretinoin. J Dermatol Treat 1993;4 (Suppl. 2):S6–9. Cross Ref link .
- 232 Etanercept and efalizumab for the treatment of psoriasis: a systematic review. Health Technol Assess 2006;10:1–233. Pubmed link , , , et al.
- 233 Economic evaluation of etanercept in the management of chronic plaque psoriasis. Br J Dermatol 2009;160:380–6. Cross Ref link Pubmed link , , , et al.
- 234 The development of a preference‐based measure of health in children with atopic dermatitis. Br J Dermatol 2005;153:372–7. Cross Ref link Pubmed link , , , et al.
- 235 A cost–utility analysis of pimecrolimus vs. topical corticosteroids and emollients for the treatment of mild and moderate atopic eczema. Br J Dermatol 2006;154:1137–46. Cross Ref link Pubmed link , , .
- 236 Cost‐effectiveness analysis of a patient‐centered care model for management of psoriasis. J Am Acad Dermatol 2012;66:563–70. Cross Ref link Pubmed link , , .
- 237 Health‐related quality‐of‐life measurement in children and adolescents: a systematic review of generic and disease‐specific instruments. Value Health 2007;11:742–64. Cross Ref link Pubmed link , , , et al.
- 238 Quality of life in pediatric dermatology. Dermatol Clin 2013;31:211–21. Cross Ref link Pubmed link , , .
- 239 The Children's Dermatology Life Quality Index (CDLQI): initial validation and practical use. Br J Dermatol 1995;132:942–9. Cross Ref link Pubmed link , .
- 240 The Children's Dermatology Life Quality Index: validation of the cartoon version. Br J Dermatol 2003;148:285–90. Cross Ref link Pubmed link , , , et al.
- 241 Clinical experience and psychometric properties of the Children's Dermatology Life Quality Index (CDLQI), 1995–2012. Br J Dermatol 2013;169:734–59. Cross Ref link Pubmed link , , , et al.
- 242 Screening for psychosocial dysfunction in pediatric dermatology practice. Clin Pediar 1991;30:493–7. Cross Ref link , , , et al.
- 243 Adolescents with skin disease have specific quality of life issues. Dermatology 2009;218:357–66. Cross Ref link Pubmed link , , , .
- 244 Development and Validation of Skindex‐Teen, a quality‐of‐life instrument for adolescents with skin disease. Arch Dermatol 2010;146:865–9. Cross Ref link Pubmed link , , , , , .
- 245 Development and validation of Teenager's quality of life (T‐QoL)© Index: a dermatology specific measure for adolescents. J Invest Dermatol 2013;133 (Suppl. 1):S95. , , .
- 246 The family impact of skin disease: the Greater Patient concept. Br J Dermatol 2007;156:929–37. Cross Ref link Pubmed link , .
- 247 Effect of childhood eczema and asthma on parental sleep and well‐being: a prospective comparative study. Br J Dermatol 2006;154:514–18. Cross Ref link Pubmed link , , , et al.
- 248 Development of a questionnaire to measure health‐related quality of life in parents of children with atopic dermatitis. Qual Life Res 1998;7:656–7. , , , .
- 249 Development of the Childhood Atopic Dermatitis Impact Scale: initial validation of a quality‐of‐life measure for young children with atopic dermatitis and their families. J Invest Dermatol 2005;125:1106–11. Cross Ref link Pubmed link , , , et al.
- 250 The Dermatitis Family Impact questionnaire: a review of its measurement properties and clinical application. Br J Dermatol 2013;169:31–46. Cross Ref link Pubmed link , , , .
- 251 Are quality of family life and disease severity related in childhood atopic dermatitis? J Eur Acad Dermatol Venereol 2002;16:455–62. Cross Ref link Pubmed link , , .
- 252 Quality‐of‐life outcomes and measurement in childhood atopic dermatitis. Immunol Allergy Clin North Am 2010;30:281–8. Cross Ref link Pubmed link , .
- 253 Atopic dermatitis: impact on the quality of life of patients and their partners. Dermatology 2007;215:123–9. Cross Ref link Pubmed link , , , et al.
- 254 The Family Dermatology Life Quality Index: measuring the secondary impact of skin disease. Br J Dermatol 2007;156:528–38. (Erratum. Br J Dermatol 2007;156:791.) Cross Ref link Pubmed link , , .
- 255 Measurement of family impact of skin disease: further validation of the Family Dermatology Life Quality Index (FDLQI). J Eur Acad Dermatol Venereol 2008;22:813–21. Cross Ref link Pubmed link , , , .
- 256 Divergent beliefs about psoriasis are associated with increased psychological distress. J Invest Dermatol 2004;123:49–56. Cross Ref link Pubmed link , , , et al.
- 257 Psoriasis has a major impact on the lives of family members and partners. Br J Dermatol 2007;156:1245–50. Cross Ref link Pubmed link , , .
- 258 PFI‐14©: A Rasch Analysis Refinement of the Psoriasis Family Index. Dermatology 2015;231(1):15–23. Cross Ref link Pubmed link , , , , , .
- 259 The Greater Patient concept. Br J Dermatol 2008;158:176–8. Pubmed link , , .
- 260 The development and validation of the Family Reported Outcome Measure (FROM‐16)© to assess the impact of disease on the partner or family member. Qual Life Res 2014;23:317–26. Cross Ref link Pubmed link , , , .
- 261 The impact of patients' chronic disease on family quality of life: an experience from 26 specialties. Int J Gen Med 2013;6:787–98. Cross Ref link Pubmed link , , , .
- 262 The three dimensions of skin disease burden: ‘now’, ‘long term’ and ‘family’. Br J Dermatol 2013;169:963–4. Cross Ref link Pubmed link .
- 263 Psoriasis: is the impairment to a patient's life cumulative? J Eur Acad Dermatol Venereol 2010;24:989–1004. Pubmed link , , , , , .
- 264 Chronic diseases influence major life changing decisions: a new domain in quality of life research. J R Soc Med 2011;104:241–50. Cross Ref link Pubmed link , , .
- 265 Chronic disease influences over 40 major life‐changing decisions (MLCDs): a qualitative study in dermatology and general medicine. J Eur Acad Dermatol Venereol 2014 Oct;28(10):1344–55. Cross Ref link Pubmed link , , , et al.
- 266 The development and validation of the major life changing decision profile (MLCDP). Health Qual Life Outcomes 2013;11:78. Cross Ref link Pubmed link , , , et al.
- 267 Involving the patient: impact of inflammatory skin disease and patient‐focused care. J Am Acad Dermatol 2005;53:S78–85. Cross Ref link Pubmed link , , , .
- 268 Patient‐based medicine. J Eur Acad Dermatol Venereol 2006;20 (Suppl. 2):73–6. Cross Ref link .
- 269 Clinical management decisions are related to the impact of psoriasis on patient‐rated quality of life. Br J Dermatol 2005;152:1256–62. Cross Ref link Pubmed link , , .
- 270 Does enough quality‐of ‐life related discussion occur during dermatology outpatient consultations? Br J Dermatol 2005;153:997–1000. Cross Ref link Pubmed link , , , .
- 271 The practical reality of using a patient‐reported outcome measure in a routine dermatology clinic. Dermatology 2007;215:315–19. Cross Ref link Pubmed link , , .
- 272 Measurement of vital signs for skin diseases. J Invest Dermatol 2005;125(4):viii–ix. Cross Ref link Pubmed link .
- 273 Health‐Related quality of life: from health economics to bedside? Dermatology 2007;215:273–6. Cross Ref link Pubmed link .